April 24th 2024
Citing a need for more Chemistry Manufacturing and Controls information, Abeona intends to address the requirements quickly.
FDA Grants Breakthrough Therapy Designation to Bispecific Antibody for Follicular Lymphoma
November 27th 2023AbbVie and Genmab will share commercial responsibilities in the United States and Japan for epcoritamab-bysp (Epkinly) for the treatment of adults with follicular lymphoma that is relapsed or refractory following treatment with two or more therapies.